ITSA :$ 60000 for 2 drugs in Phase 2B is not much thanks to Diamond and the ANP Board.....???????
Then what are these extraordinary huge amounts thta appeared on the 6 months financial report :
1 - administrative expenses. $ 555,102.00
2- Business development expense. $ 432,074.00
3- Research and development expenses$ 446,483.00
Forget about nr. 3 which is what ANP business it is all about
Now only add nr. 1 and 2 and tell me how thankful should we all be to Diamond and the rest of the Board
and what for ? What is the business development expenses exactly in a bio company that already has research and development expenses ? Go on ITSA please let all of us know how intense should our gratitude be to Diamond ?
Ann: Market and Technology Update, page-82
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.002(2.47%) |
Mkt cap ! $82.94M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.9¢ | $197.1K | 2.487M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 141739 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 453479 | 7 |
View Market Depth
| Last trade - 15.15pm 01/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |